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Abstract The two P domain hTRAAK K+ channel has been
cloned from human brain. hTRAAK cDNA encodes a 393 amino
acid polypeptide with 88% of homology with its mouse counter-
part. The hTRAAK gene has been mapped to chromosome 11q13
and the study of its organization indicates that the hTRAAK
open reading frame is contained in six exons. hTRAAK is
expressed abundantly in brain and placenta. In COS cells,
hTRAAK currents are K+-selective, instantaneous and non-
inactivating. These currents are insensitive to the classical K+
channels blockers 4-aminopyridine, tetraethylammonium, barium
and quinidine, but are strongly stimulated by application of
arachidonic acid as well as other polyunsaturated fatty acids.
hTRAAK can also be activated by a stretch of the membrane.
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1. Introduction
Mammalian K channels with four transmembrane seg-
ments and two pore domains in tandem form a novel class
of K channels. To date, seven members of this family have
been cloned [1^8]. Despite an overall similar structure, the
sequence identity between these channels is low (less than
30%). TWIK-1 and TWIK-2 are weak inward rectifying K
channels. TASK-1 and TASK-2 are outward rectifying K
channels sensitive to variations of extracellular pH in a nar-
row physiological range. TREK-1, another outward rectifying
channel, is activated by membrane stretch, polyunsaturated
fatty acids, intracellular acidosis and inhalational anesthetics
[9^11]. All these two P domain K channels have a wide-
spread tissue distribution. TRAAK, the second cloned mecha-
no-gated and polyunsaturated fatty acids-activated K chan-
nel, is the sole to be expressed exclusively in the mouse central
nervous system [5,12,13]. Here we describe the cloning and
functional expression of human TRAAK. hTRAAK shares
all the functional properties of its mouse counterpart and is
also mainly expressed in neuronal tissues [5,12].
2. Materials and methods
2.1. cDNA cloning
Sequences of two P domain K channels were used to search ho-
mologs in public DNA databases by using the Blast program [14].
This led to the identi¢cation of a genomic sequence (GenBank acces-
sion number AC005848) which showed signi¢cant similarities with
mouse TRAAK. Two oligonucleotides were designed from this ge-
nomic sequence corresponding to the equivalent sequences £anking
the ¢rst initiation codon and the stop codon of mTRAAK: sense
strand: 5P-AGAATTCGCGCCATGCGCAGCACCACG-3P and anti-
sense strand: 5P-TTTCTCGAGGCCCGGCCAGGGATCCTG-3P in-
troducing EcoRI and XhoI restriction sites, respectively. The entire
coding sequence was ampli¢ed from human brain cDNA by PCR
using these primers and a low-error rate DNA polymerase, then sub-
cloned into the pIRES-CD8 vector to give pIRES-CD8-hTRAAK.
Inserts from di¡erent independent PCR-ligation experiments were se-
quenced on both strands and found to be identical.
2.2. Chromosomal mapping
The Genebridge 4 RH DNA panel (Research Genetics) was
screened by PCR using primers deduced from intron 5 (sense primer:
5P-ACCCAGTGGAGGAGCCCTTC-3P) and exon 6 (antisense prim-
er: 5P-GAGGCCCGGCCAGGGATCCTG-3P). PCR conditions were
39 cycles of 30 s at 94‡C, 30 s at 55‡C, and 30 s at 72‡C. PCR
products were separated by electrophoresis on agarose then trans-
ferred onto charged nylon membranes. Blots were probed with a
32P-labeled oligonucleotide 5P-CCAGGCTGCCAGCTGGACRG-3P.
The results were analyzed by using the RH-MAPPER program at
Whitehead Institute (http://www.genome.wi.mit.edu).
2.3. RT-PCR experiment
Multiple Tissue cDNA panels (Clontech) were used as template
according to the manufacturer’s protocol. Sequences of primers
were sense primer: 5P-CTCAGTGCTCACCACCATCG-3P (exon 5)
and antisense primer: 5P-GAGGCCCGGCCAGGGATCCTG-3P
(exon 6). The PCR conditions were 34 cycles of 30 s at 94‡C, 30s at
55‡C, and 1 min at 72‡C. PCR products were separated, transferred,
and probed as described for chromosomal mapping.
2.4. Cell culture and transfection
COS-7 cells were maintained in Dulbecco’s modi¢ed Eagle’s me-
dium supplemented with 10% fetal bovine serum. The pIRES-cD8-
hTRAAK plasmid was transfected using the classical DEAE dextran
procedure. The positive cells were visualized 48 h after transfection
using the anti-CD8 antibody-coated bead method.
2.5. Electrophysiology
For whole cell and outside-out experiments, the pipette solution
(INT) contained 150 mM KCl, 3 mM MgCl2, 5 mM EGTA and
10 mM HEPES, pH 7.2 adjusted with KOH. The bath solution
(EXT) contained 150 mM NaCl, 5 mM KCl, 3 mM MgCl2, 1 mM
CaCl2 and 10 mM HEPES, pH 7.4 adjusted with NaOH. For inside-
out experiments the solution in the pipette was EXT and the bath
solution was INT. The EXT K-rich solution contained 150 mM KCl
instead of 150 mM NaCl. To study the ion selectivity, current^voltage
relationships were obtained at di¡erent [K]ext. For each concentra-
tions, NaCl was substituted in the EXT solution with equimolar
KCl.
All products were obtained from Sigma. Fatty acids were dissolved
in the ethanol at the concentration of 100 mM, £ushed under argon
and kept at 320‡C for a week. Mechanical stimulation was applied
through an open loop pressure generating system and monitored at
the level of the patch pipette throughout the experiment by a cali-
brated pressure sensor.
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3. Results and discussion
3.1. Primary structure and gene organization and mapping
Searches of DNA databases using the Blast sequence align-
ment program [14] led to the identi¢cation of human sequen-
ces restrained to a single genomic contig. The analysis of these
sequences suggested the presence of introns and exons form-
ing a gene encoding a two P domain K channel. Oligonu-
cleotides were deduced from the potential exon sequences and
used to PCR-amplify a DNA fragment containing the corre-
sponding open reading frame from brain cDNAs. This ORF
is 1182 nucleotides long and encodes a 393 amino acid poly-
peptide (Fig. 1). This protein is closely related to the mouse
TRAAK channel with 82% of identity and 88% of homology.
This homology level, together with the conserved tissue dis-
tribution and functional properties that are shown hereafter,
indicates that the novel channel is the human counterpart of
the mouse TRAAK. Fig. 1B shows the TRAAK cDNA se-
quence and genomic organization in human. The ORF is
composed of six exons. The transmembrane segment M1 is
encoded by exon 1, M2 by exon 3, M3 by exon 4, and M4 by
exon 5. The second exon encodes the carboxy-terminal part of
the M1P1 interdomain and the sixth one encodes the large
carboxy-terminal part of the channel (Fig. 1A,B). Introns
are short except the ¢rst one that is more than 3.8 kb long
(Fig. 1B). A gene encoding another mammalian two P domain
K channel, TWIK-1, has already been characterized [15]. The
genomic organizations of TRAAK and TWIK-1 are quite dif-
ferent because TWIK-1 contains only three exons separated
by two large introns. However, a common feature between the
two genes is the presence of an intron in the ¢rst pore-domain
P1. The intron site is between the ¢rst and the second nucle-
otide of the codon for the ¢rst glycine residue of the pore
signature sequence GYG [15]. An intron in the same position
is found in 20 genes among the 36 examined that encode
potential two P domain K channels in the nematode Caeno-
rhabditis elegans [16]. The signi¢cance of this conserved intron
position is not known, however it is worth to note that this
intron has been conserved in mammals where it might even-
tually have the same role as in the nematode.
The chromosomal assignment of human TRAAK was car-
ried out by radiation hybrid panel analysis. As shown in Fig.
2, the gene encoding TRAAk lies on chromosome 11q and is
5.34 cRays telomeric to the framework marker WI-1409 (Log-
arithm of odds score s 21). Although radiation hybrid maps
are not anchored to the cytogenic maps, the most likely local-
ization of the TRAAK gene is 11q13. KCNK7 that encodes a
related two P domain K channel has been mapped on chro-
mosome 11q13 at 6.4 cRays telomeric to WI-1409. This sug-
gests that TRAAK and KCNK7 are very close each other [8].
3.2. Tissue distribution
The expression of TRAAK in various adult human tissues
was examined by RT-PCR analysis. As shown in Fig. 3,
TRAAK is expressed at the highest levels in brain and pla-
centa. Only very faint signals were obtained in testis, small
Fig. 1. A: Topology of human TRAAK. The relative positions of
introns are indicated by arrows. B: TRAAK cDNA and genomic
sequences. Coding sequence is in upper cases and genomic sequence
corresponding to splice sites in lowercase. M1 to M4 transmem-
brane segments are in light gray, and P1 and P2 pore-domains in
dark gray. The size of introns is indicated in bold.
Fig. 2. Idiogram of human G-banded chromosome 11q and location
of the TRAAK gene relative to markers mapped in the Genebridge
4 RH panel.
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intestine, prostate and kidney. TRAAK was not detected in
the mouse placenta [5]. The reason of this discrepancy is not
known. In the mouse, TRAAK is highly expressed only in
neuronal tissues, as in humans. In situ hybridization [5] and
immunohistology [13] have demonstrated that mouse
TRAAK is speci¢cally expressed in neuronal cells. The tissue
distribution shown in Fig. 3 suggests that TRAAK could have
the same restricted pattern of expression in humans.
3.3. Biophysical properties
The electrophysiological experiments were performed in
transiently transfected COS cells. hTRAAK current has no
apparent voltage activation threshold, is time-independent
and non-inactivating (Fig. 4A). The I^V curve is outward
rectifying and noisy at positive potentials (Fig. 4A,B). In a
physiological condition (5 mM K ext), hTRAAK current
reverses at the predicted value for the K equilibrium
(387.1 þ 1.2 mV, n = 6). When the external Na is substituted
with K the reversal potential closely follows the value for the
K equilibrium (Fig. 4C). The slope of the regression line is
58.6 þ 0.6 mV per 10-fold change in [K]ext (n = 6) which is in
agreement with the Nernst equation for a K selective chan-
nel. In a symmetrical condition (155 mM K ext), the I^V
curve is less outward rectifying (Fig. 4A,B) and reverses at
0.8 þ 1.1 mV (n = 6). The pharmacological properties of
hTRAAK were investigated in the whole cell con¢guration.
hTRAAK is insensitive to the classical K channel blockers
quinidine (100 WM), 4AP (3 mM), TEA (10 mM), barium (1
mM) and glibenclamide (10 WM). Some members of the two P
domains K channels family (TREK-1 and TASK-1) have
been shown to be opened by volatile general anesthetics
[11]. We then investigated the e¡ect of chloroform on
hTRAAK. Application of chloroform (0.8 mM, n = 8) has
no e¡ect on the channel activity. The single channel properties
of hTRAAK are illustrated in Fig. 1D. At the microscopic
level, in physiological K condition, the hTRAAK current is
outwardly rectifying and is characterized by a £ickering be-
havior.
The mouse TRAAK is stimulated by the poly-unsaturated
fatty acids [5,12]. Fig. 5A,B shows that human TRAAK ac-
tivity is also potentiated by 10 WM of arachidonic acid (AA)
in the whole cell con¢guration (630 þ 101% at 0 mV, n = 19).
This activation is completely reversible upon washout (Fig.
5A, inset). In physiological condition, the AA-induced current
is outward rectifying and reverses at 380.6 þ 0.9 mV, n = 7
(Fig. 5A). When the external Na is substituted with K,
the current becomes linear and the reversal potential shifts
to 30.6 þ 0.8 mV, n = 7 (Fig. 5B). hTRAAK is also activated
by the poly-unsaturated fatty acid docosahexaenoate (10 WM,
n = 3) but insensitive to the saturated fatty acids myristate,
palmitate, stearate, arachidate (10 WM, n = 6^8). Moreover,
AA derivatives with an alcohol or a methyl ester substituted
in the carboxylic function are inactive (n = 5). The AA-stim-
ulation of hTRAAK remains when the patch is excised (Fig.
5C). The AA-induced current observed in the outside-out con-
¢guration is outward rectifying and reverses at the K rever-
sal potential (Fig. 5C, inset). We have demonstrated that the
two P domains K channels activated by the polyunsaturated
fatty acids (mTREK-1 and mTRAAK) are mechano-gated
K channels. Channel opening is mediated by membrane de-
formation [10,12]. Fig. 5D illustrates the mechano-sensitivity
of hTRAAK. In the inside-out patch con¢guration, channel
activity is almost absent at atmospheric pressure. Application
of negative pressure opens the channels in a dose-dependent
manner. Taken together, these results demonstrate that hu-
man TRAAK shares the same biophysical and pharmacolog-
Fig. 3. Tissue distribution of TRAAK in human adult tissues as de-
termined by RT-PCR analysis. The ampli¢ed products were ana-
lyzed by Southern blot. GAPDH was ampli¢ed to check the integ-
rity of cDNA.
Fig. 4. Biophysical properties of the human TRAAK. A: Currents
elicited by voltage pulses in 20 mV increments from 3120 mV to
100 mV in a physiological condition (5 mM K ext), left panel or
in a symmetrical condition (155 mM K ext), right panel. The hold-
ing potential is 380 mV and the zero current is indicated by hori-
zontal arrows. B: current^voltage (I^V) curves of the hTRAAK in
physiological and symmetrical K conditions. The holding potential
is 380 mV and voltage ramps of 800 ms in duration are applied
every 10 s from 3130 to 100 mV. C: Reversal potential of
hTRAAK current (Erev) as a function of [K]ext (n = 6). D: Single
channel hTRAAK currents recorded in physiological K condition,
in the inside-out con¢guration at 350, 0 and 50 mV.
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ical properties as its mouse counterpart and has similar prop-
erties to K currents previously identi¢ed in the central nerv-
ous system [17]. Together with hTREK-1, hTRAAK consti-
tutes a novel class of AA- and stretch-activated K channels
in human.
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Fig. 5. hTRAAK is an AA-activated and a mechano-gated K channel. A: Whole cell recording of a hTRAAK-transfected COS cell illustrat-
ing the e¡ect of 10 WM AA. I^V curves were constructed using the same protocol as in Fig. 4B. The bath solution is EXT (5 mM K). The in-
set shows a typical current recorded at 0 mV during the application of 10 WM AA. The zero current is indicated by a horizontal dashed line (a
di¡erent cell from A). B: I^V curve performed with the EXT K-rich solution. (same cell as in A). C: Outside-out patch clamp experiment
showing the e¡ect of 10 WM AA on a hTRAAK-transfected COS cell. The patch is maintained at 0 mV. The zero current is indicated by a
horizontal dashed line. The inset shows the current^voltage relationship of such an experiment (a di¡erent cell from C). D: Graded reversible
negative pressure activation of hTRAAK in physiological K condition, in the inside-out con¢guration. The patch is held at 0 mV and the
zero current is indicated by a dashed line.
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